Autologous PRP & dextrose prolotherapy equally effective in recalcitrant plantar fasciitis
Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitisPM R. 2014 Feb;6(2):152-8. doi: 10.1016/j.pmrj.2013.07.003.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
21 patients diagnosed with chronic recalcitrant plantar fasciitis were randomized to receive either dextrose prolotherapy (DP) or autologous platelet-rich plasma (PRP) injection therapy. The purpose was to evaluate the efficacies of these treatments and additionally, to assess whether one is more effective. Results at 28 weeks indicated that both treatments significantly improved total Foot Functi...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE